Alliance Urology Specialists — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$762	4
2021	Research	$25,534	7
2020	Research	$16,770	9
2019	Research	$13,838	2

Breakdown

Who paid Research payments · program years 2019–2023

Janssen Research & Development, LLC $55,009 17 payments
Allergan Inc. $1,133 1 payment
Sumitomo Pharma America, Inc. $551 1 payment
Medtronic, Inc. $211 3 payments

Studies the money was for Research payments · program years 2019–2023

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy $29,475 10 payments
A Randomized Double blind Placebo controlled Phase 3 Study of Apalutamide in Subjects with High risk Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy $25,534 7 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate An Enhanced Injection Paradigm for Onabotulinumtoxina Botox in the Treatment of Overactive Bladder in Patients With Urinary Incontinence $1,133 1 payment
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) $551 1 payment
Titan 2 $211 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.